Hasil Pencarian (1)
small molecule | CAS: 1609392-27-9
Deucravacitinib is a novel oral selective tyrosine kinase 2 (TYK2) inhibitor. Unlike other Janus kinase 1/2/3 inhibitors that bind to the conserved active domain of these non-receptor tyrosine kinases, deucravacitinib binds to the regulatory domain of TYK2 wi…
Kategori:
Antineoplastic and Immunomodulating AgentsBCRP/ABCG2 InhibitorsBCRP/ABCG2 Substrates
+17
Target Protein:
Non-receptor tyrosine-protein kinase TYK2
Waktu ParuhThe terminal half-l…
Vol. DistribusiThe volume of distr…
KlirensThe renal clearance…
Genetik
-